Integrating experimental (in vitro and in vivo) neurotoxicity studies of low-dose thimerosal relevant to vaccines

Neurochemical Research

Volumn 36, Issue 6, 2011, Pages 927-938

  Dórea, José G ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Children; Ethylmercury; Infants; Neurodevelopment; Pregnancy; Thimerosal

Indexed keywords

HEPATITIS B VACCINE; INFLUENZA VACCINE; MESSENGER RNA; THIOMERSAL;

ANIMAL BEHAVIOR; BRAIN CELL; CELL DEATH; CELL ISOLATION; DOSE RESPONSE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; TASK PERFORMANCE; TOXICITY TESTING; VACCINATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; THIMEROSAL; VACCINES;

ANIMALIA;

EID: 79955686794     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-011-0427-0     Document Type: Review

References (81)

1. Grandjean P, Landrigan PJ (2006) Developmental neurotoxicity of industrial chemicals. Lancet 368(9553):2167-2178
2. Palmer RF, Blanchard S, Stein Z et al (2006) Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 12:203-209
3. Ishitobi H, Stern S, Thurston SW (2010) Organic and inorganic mercury in neonatal rat brain after prenatal exposure to methylmercury and mercury vapor. Environ Health Perspect 118:242-248
4. Warkany J, Hubbard DM (1953) Acrodynia and mercury. J Pediatr 42:365-386
5. HO W (2000) Thiomersal as a vaccine preservative. Weekly Epidemiol Record 75:12-16
6. da Costa SL, Malm O, Dórea JG (2005) Breast-milk mercury concentrations and amalgam surface in mothers from Brasília, Brazil. Biol Trace Elem Res 106:145-151
7. Seal D, Ficker L, Wright P et al (1991) The case against thiomersal. Lancet 338:315-316
8. Karincaoglu Y, Aki T, Erguvan-Onal R et al (2007) Erythema multiforme due to diphtheria-pertussis-tetanus vaccine. Pediatr Dermatol 24:334-335
9. Halsey NA, Goldman L (2001) Balancing risks and benefits: primum non nocere is too simplistic. Pediatrics 108:466-467
10. Clements CJ (2004) The evidence for the safety of thiomersal in newborn and infant vaccines. Vaccine 22:1854-1861
11. Lapphra K, Huh L, Scheifele DW (2010) Adverse neurologic reactions after both doses of pandemic H1N1 influenza vaccine with optic neuritis and demyelination. Pediatr Infect Dis J (in press)
12. Ratajczak HV (2011) Theoretical aspects of autism: causes? A review. J Immunotoxicol 8:68-79
13. Dórea JG (2010) Research into mercury exposure and health education in subsistence fish-eating communities of the Amazon Basin: potential effects on public health policy. Int J Environ Res Public Health 7:3467-3477
14. Knezevic I, Griffiths E, Reigel F (2004) Thiomersal in vaccines: a regulatory perspective WHO Consultation, Geneva, 15-16 April 2002. Vaccine 22:1836-1841
15. Freed GL, Clark SJ, Butchart AT et al (2010) Parental vaccine safety concerns in 2009. Pediatrics 125:654-659
16. Sears R (2010) The autism book: what every parent needs to know about early detection, treatment, recovery, and prevention. Little Brown
17. Austin DW, Shandley KA, Palombo EA (2010) Mercury in vaccines from the Australian childhood immunization program schedule. J Toxicol Environ Health A 73:637-640
18. Siegrist CA (2010) Vaccine update 2009: questions around the safety of the influenza A (H1N1) vaccine. Rev Med Suisse 6:67-70
19. Stetler HC, Garbe PL, Dwyer DM et al (1985) Outbreaks of group A streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccination. Pediatrics 75:299-303
20. Puziss M, Wright GG (1963) Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man. J Bacteriol 85:230-236
21. Nelson EA, Gottshall RY (1967) Enhanced toxicity for mice of pertussis vaccines when preserved with Merthiolate. Appl Microbiol 15:590-593
22. Geier DA, Jordan SK, Geier MR (2010) The relative toxicity of compounds used as preservatives in vaccines and biologics. Med Sci Monitor 16:SR21-SR27
23. Mayrink W, Tavares CA, de Deus RB (2010) Comparative evaluation of phenol and thimerosal as preservatives for a candidate vaccine against American cutaneous leishmaniasis. Mem Inst Oswaldo Cruz 105:86-91
24. Chanez C, Flexor MA, Bourre JM (1989) Effect of organic and inorganic mercuric salts on Na+K+ATPase in different cerebral fractions in control and intrauterine growth-retarded rats: alterations induced by serotonin. Neurotoxicology 10:699-706
25. Rush T, Hjelmhaug J, Lobner D (2009) Effects of chelators on mercury, iron, and lead neurotoxicity in cortical culture. Neurotoxicology 30:47-51
26. Ueha-Ishibashi T, Oyama Y, Nakao H et al (2004) Effect of thimerosal, a preservative in vaccines, on intracellular Ca2+ concentration of rat cerebellar neurons. Toxicology 195:77-84
27. James SJ, Slikker W, Melnyk S et al (2005) Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicology 26:1-8
28. Minami T, Miyata E, Sakamoto Y (2009) Expression of metallothionein mRNAs on mouse cerebellum microglia cells by thimerosal and its metabolites. Toxicology 261:25-32
29. Baskin DS, Ngo H, Didenko VV (2003) Thimerosal induces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblasts. Toxicol Sci 74:361-368
30. Yel L, Brown LE, Su K et al (2005) Thimerosal induces neuronal cell apoptosis by causing cytochrome c and apoptosis-inducing factor release from mitochondria. Int J Mol Med 16:971-977
31. Humphrey ML, Cole MP, Pendergrass JC et al (2005) Mitochondrial mediated thimerosal-induced apoptosis in a human neuroblastoma cell line (SK-N-SH). Neurotoxicology 26:407-416
32. Herdman ML, Marcelo A, Huang Y et al (2006) Thimerosal induces apoptosis in a neuroblastoma model via the cJun N-terminal kinase pathway. Toxicol Sci 92:246-253
33. Geier DA, King PG, Geier MR (2009) Mitochondrial dysfunction, impaired oxidative-reduction activity, degeneration, and death in human neuronal and fetal cells induced by low-level exposure to thimerosal and other metal compounds. Toxicol Environ Chem 91:735-749
34. Parran DK, Barker A, Ehrich M (2005) Effects of thimerosal on NGF signal transduction and cell death in neuroblastoma cells. Toxicol Sci 86:132-140
35. Waly M, Olteanu H, Banerjee R et al (2004) Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry 9:358-370
36. James SJ, Rose S, Melnyk S et al (2009) Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J 23:2374-2383
37. Jin Y, Kim DK, Khil LY et al (2004) Thimerosal decreases TRPV1 activity by oxidation of extracellular sulfhydryl residues. Neurosci Lett 369:250-255
38. Song J, Jang YY, Shin YK et al (2000) Inhibitory action of thimerosal, a sulfhydryl oxidant, on sodium channels in rat sensory neurons. Brain Res 864:105-113
39. Lawton M, Iqbal M, Kontovraki M et al (2007) Reduced tubulin tyrosination as an early marker of mercury toxicity in differentiating N2a cells. Toxicol In Vitro 21:1258-1261
40. Zieminska E, Toczylowska B, Stafiej A et al (2010) Low molecular weight thiols reduce thimerosal neurotoxicity in vitro: modulation by proteins. Toxicology 276:154-163
41. Wyrembek P, Szczuraszek K, Majewska MD et al (2010) Inter-mingled modulatory and neurotoxic effects of thimerosal and mercuric ions on electrophysiological responses to GABA and NMDA in hippocampal neurons. J Physiol Pharmacol 61:753-768
42. Toimela T, Tahti H (2004) Mitochondrial viability and apoptosis induced by aluminum, mercuric mercury and methylmercury in cell lines of neural origin. Arch Toxicol 78:565-574
43. Campbell A, Hamai D, Bondy SC (2001) Differential toxicity of aluminum salts in human cell lines of neural origin: implications for neurodegeneration. Neurotoxicol 22:63-71
44. Redwood L, Bernard S, Brown D (2001) Predicted mercury concentrations in hair from infant immunizations: cause for concern. Neurotoxicology 22:691-697
45. Aschner M, Ceccatelli S (2010) Are neuropathological conditions relevant to ethylmercury exposure? Neurotox Res 18:59-68
46. Echeverria D, Woods JS, Heyer NJ et al (2010) The association between serotonin transporter gene promoter polymorphism (5-HTTLPR) and elemental mercury exposure on mood and behavior in humans. J Toxicol Environ Health 73:552-569
47. Ceccatelli S, Daré E, Moors M (2010) Methylmercury-induced neurotoxicity and apoptosis. Chem Biol Interact 188:301-308
48. Clarkson TW, Nordberg GF, Sager PR (1985) Reproductive and developmental toxicity of metals. Scand J Work Environ Health 11:145-154
49. Blair A, Clark B, Clarke A et al (1975) Tissue concentrations of mercury after chronic dosing of squirrel monkeys with thimerosal. Toxicology 3:171-176
50. Burbacher TM, Shen DD, Liberato N et al (2005) Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 113:1015-1021
51. Vahter M, Mottet NK, Friberg L et al (1994) Speciation of mercury in the primate blood and brain following long-term exposure to methyl mercury. Toxicol Appl Pharmacol 124:221-229
52. Gassett AR, Itoi M, Ishii Y et al (1975) Teratogenicities of ophthalmic drugs II. Teratogenicities and tissue accumulation of thimerosal. Arch Ophthalmol 93:52-55
53. Minami T, Oda K, Gima N et al (2007) Effects of lipopolysaccharide and chelator on mercury content in the cerebrum of thimerosal-administered mice. Environ Toxicol Pharmacol 24:316-332
54. Minami T, Miyata E, Sakamoto Y et al (2010) Induction of metallothionein in mouse cerebellum and cerebrum with low-dose thimerosal injection. Cell Biol Toxicol 26:143-152
55. Orct T, Blanusa M, Lazarus M et al (2006) Comparison of organic and inorganic mercury distribution in suckling rat. J Appl Toxicol 26:536-539
56. Zareba G, Cernichiari E, Hojo R et al (2007) Thimerosal distribution and metabolism in neonatal mice: comparison with methyl mercury. J Appl Toxicol 27:511-518
57. Rodrigues JL, Serpeloni JM, BL Batista et al (2010) Identification and distribution of mercury species in rat tissues following administration of thimerosal or methylmercury. Arch Toxicol 84:891-896
58. Ekstrand J, Nielsen JB, Havarinasab S et al (2010) Mercury toxicokinetics-dependency on strain and gender. Toxicol Appl Pharmacol 243:283-291
59. Branch DR (2009) Gender-selective toxicity of thimerosal. Exp Toxicol Pathol 61:133-136
60. Harry GJ, Harris MW, Burka LT (2004) Mercury concentrations in brain and kidney following ethylmercury, methylmercury and Thimerosal administration to neonatal mice. Toxicol Lett 154:183-189
61. Gibičar D, Logar M, Horvat N et al (2007) Simultaneous determination of trace levels of ethylmercury and methylmercury in biological samples and vaccines using sodium tetra(n-propyl) borate as derivatizing agent. Anal Bioanal Chem 388:329-340
62. Dórea JG, Wimer W, Marques RC et al. (2010) Automated speciation of mercury in hair of breastfed infants exposed to ethylmercury from Thimerosal-containing vaccines. Biol Trace El Res (in press)
63. Mutter J, Curth A, Naumann J et al. (2010) Does inorganic mercury play a role in alzheimer's disease? A systematic review and an integrated molecular mechanism. J Alzheimers Dis (in press)
64. Dórea JG, Marques RC (2010) Infants' exposure to aluminum from vaccines and breast milk during the first 6 months. J Expo Sci Environ Epidemiol 20:598-601
65. Burrell SA, Exley C (2010) There is (still) too much aluminium in infant formulas. BMC Pediatr 10:63
66. Petrik MS, Wong MC, Tabata RC et al (2007) Aluminum adjuvant linked to Gulf War illness induces motor neuron death in mice. Neuromolecular Med 9:83-100
67. Flarend RE, Hem SL, White JL et al (1997) In vivo absorption of aluminium-containing vaccine adjuvants using 26Al. Vaccine 15:1314-1318
68. Shaw CA, Petrick MS (2009) Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. J Inorg Biochem 103:1555-1562
69. Olczak M, Duszczyk M, Mierzejewski P et al (2010) Neonatal administration of thimerosal causes persistent changes in mu opioid receptors in the rat brain. Neurochem Res 35:1840-1847
70. Olczak M, Duszczyk M, Mierzejewski P et al (2010) Lasting neuropathological changes in rat brain after intermittent neonatal administration of thimerosal. Folia Neuropathol 48:258-269
71. Hornig M, Chian D, Lipkin WI (2004) Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 9:833-845
72. Berman RF, Pessah IN, Mouton PR et al (2008) Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice. Toxicol Sci 101:294-309
73. Olczak M, Duszczyk M, Mierzejewski P et al (2009) Neonatal administration of a vaccine preservative, thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats. Brain Res 1301:143-151
74. Hewitson L, Lopresti BJ, Stott C et al (2010) Influence of pediatric vaccines on amygdala growth and opioid ligand binding in rhesus macaque infants: a pilot study. Acta Neurobiol Exp 70:147-164
75. Hewitson L, Houser LA, Stott C et al (2010) Delayed acquisition of neonatal reflexes in newborn primates receiving a thimerosal-containing hepatitis B vaccine: influence of gestational age and birth weight. J Toxicol Environ Health A 73:1298-1313
76. Dórea JG (2010) Making sense of epidemiological studies of young children exposed to thimerosal in vaccines. Clin Chim Acta 411:1580-1586
77. Marques RC, Dórea JG, Bernardi JV (2010) Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neuro-development of breastfed infants at six months. Acta Paediatr 99:934-939
78. Marques RC, Dórea JG, Bernardi JV et al (2009) Pre- and post-natal mercury exposure, breastfeeding and neurodevelopment during the first five years. Cognit Behav Neurol 22:134-141
79. Dórea JG, Marques RC, Brandão KG (2009) Neonate exposure to thimerosal mercury from hepatitis B vaccines. Am J Perinatol 26:523-527
80. Judson RS, Houck KA, Kavlock RJ et al (2010) In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project. Environ Health Perspect 118:485-492
81. Hunter JW, Mullen GP, McManus JR, Heatherly JM, Duke A, Rand JB (2010) Neuroligin-deficient, mutants of C. elegans have sensory processing deficits and are hypersensitive to oxidative stress and mercury toxicity. Dis Model Mech 3:366-376